ENZAMET shows promise as prostate cancer treatment
A new drug combination for men with advanced prostate cancer has shown sustained increase in survival rates.
Mar 28, 2023
0
210
MeSH tree: D02.455.426.392.368.242
A new drug combination for men with advanced prostate cancer has shown sustained increase in survival rates.
Mar 28, 2023
0
210
Immune cells that keep the brain free of debris but also contribute to inflammation are the likely culprits behind the concentration and memory problems that sometimes follow one type of chemotherapy, a new study in mice ...
Feb 28, 2023
0
59
A combination of chemotherapy and drugs that stimulate the immune system to combat cancer is increasingly used to control progression of the disease in patients. On the other hand, clinical studies show that the combination ...
Jan 30, 2023
0
73
Adding nab-paclitaxel to a standard treatment of gemcitabine plus cisplatin does not significantly extend median overall survival (OS) time for patients with advanced biliary tract cancers, although it may provide a benefit ...
Jan 20, 2023
0
50
Precision oncology aims at pointing out which drug is likely to work in every specific cancer patient. At the moment these targeted therapies are only available for 5% of cancers. The study carried out by CNIO researchers ...
Dec 14, 2022
0
51
A combination of two types of cancer-fighting treatments—the immunotherapy agent pembrolizumab and a nanoparticle-bound form of the chemotherapy drug paclitaxel—may provide an urgently needed new treatment approach for patients ...
Nov 3, 2022
0
45
Biomedical engineers at Duke University have demonstrated the most effective treatment for pancreatic cancer ever recorded in mouse models. While most mouse trials consider simply halting growth a success, the new treatment ...
Oct 20, 2022
0
295
Giving standard chemotherapy drugs in a specific sequence for some types of metastatic breast cancer can help reduce overall costs and improve the value of care while preserving quality of life, according to a study led by ...
Sep 13, 2022
0
44
A combination of two intravesical chemotherapy drugs—gemcitabine and docetaxel—yields high response rates with good tolerability in patients with high-risk non-muscle-invasive bladder cancer (NMIBC), reports a study in The ...
Jul 27, 2022
0
36
Although antiretroviral therapy has markedly improved survival in people with AIDS-associated Kaposi sarcoma (a type of cancer caused by a virus), the condition is still a life-threatening problem in low- and middle-income ...
Jul 15, 2022
0
54